日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Comparing Care Delivery Efficiency Between Emergency Department and Oncology Urgent Care

比较急诊科和肿瘤急诊科的医疗服务效率

Hong, Arthur S; Charania, Sadaf; Bazzell, Angela; Courtney, Mark; Sweetenham, John W; Fleming, Jason; Lee, Simon J Craddock; Halm, Ethan A

Impact of the Immediate Release of Clinical Information Rules on Health Care Delivery to Patients With Cancer

临床信息即时发布规则对癌症患者医疗保健服务的影响

Anyidoho, P Abena; Verschraegen, Claire F; Markham, Merry Jennifer; Alberts, Steven; Sweetenham, John; Cameron, Kendra; Abu Hejleh, Taher

Patterns and Results of Triage Advice Before Emergency Department Visits Made by Patients With Cancer

癌症患者急诊就诊前分诊建议的模式和结果

Hong, Arthur S; Chang, Hannah; Courtney, D Mark; Fullington, Hannah; Lee, Simon J Craddock; Sweetenham, John W; Halm, Ethan A

Prior Frequent Emergency Department Use as a Predictor of Emergency Department Visits After a New Cancer Diagnosis

既往频繁急诊就诊史可预测新确诊癌症后再次急诊就诊情况

Hong, Arthur S; Nguyen, Danh Q; Lee, Simon Craddock; Courtney, D Mark; Sweetenham, John W; Sadeghi, Navid; Cox, John V; Fullington, Hannah; Halm, Ethan A

COVID-19 Communication From Seven Health Care Institutions in North Texas for English- and Spanish-Speaking Cancer Patients: Mixed Method Website Study

北德克萨斯州七家医疗机构针对讲英语和西班牙语的癌症患者的 COVID-19 信息沟通:混合方法网站研究

Higashi, Robin T; Sweetenham, John W; Israel, Aimee D; Tiro, Jasmin A

US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose-Positron Emission Tomography Imaging: Southwest Oncology Group S0816

美国多中心联合试验:采用早期中期氟代脱氧葡萄糖正电子发射断层扫描成像技术对 III 期至 IV 期霍奇金淋巴瘤患者进行反应适应性治疗:西南肿瘤协作组 S0816

Press, Oliver W; Li, Hongli; Schöder, Heiko; Straus, David J; Moskowitz, Craig H; LeBlanc, Michael; Rimsza, Lisa M; Bartlett, Nancy L; Evens, Andrew M; Mittra, Erik S; LaCasce, Ann S; Sweetenham, John W; Barr, Paul M; Fanale, Michelle A; Knopp, Michael V; Noy, Ariela; Hsi, Eric D; Cook, James R; Lechowicz, Mary Jo; Gascoyne, Randy D; Leonard, John P; Kahl, Brad S; Cheson, Bruce D; Fisher, Richard I; Friedberg, Jonathan W

Quality of life results from a phase 3 study of brentuximab vedotin consolidation following autologous haematopoietic stem cell transplant for persons with Hodgkin lymphoma

一项针对霍奇金淋巴瘤患者自体造血干细胞移植后使用brentuximab vedotin巩固治疗的3期研究的生活质量结果

Ramsey, Scott D; Nademanee, Auayporn; Masszi, Tamas; Holowiecki, Jerzy; Abidi, Muneer; Chen, Andy; Stiff, Patrick; Viviani, Simonetta; Sweetenham, John W; Radford, John; Zhu, Yanyan; Bonthapally, Vijayveer; Thomas, Elizabeth; Richhariya, Akshara; Hunder, Naomi N; Walewski, Jan; Moskowitz, Craig H

Phase 1 study of the safety, pharmacokinetics, and antitumour activity of the BCL2 inhibitor navitoclax in combination with rituximab in patients with relapsed or refractory CD20+ lymphoid malignancies

一项评估BCL2抑制剂navitoclax联合利妥昔单抗治疗复发或难治性CD20+淋巴瘤患者的安全性、药代动力学和抗肿瘤活性的I期研究

Roberts, Andrew W; Advani, Ranjana H; Kahl, Brad S; Persky, Daniel; Sweetenham, John W; Carney, Dennis A; Yang, Jianning; Busman, Todd B; Enschede, Sari H; Humerickhouse, Roderick A; Seymour, John F

Mantle cell lymphoma: observation to transplantation

套细胞淋巴瘤:移植后观察

Babak Rajabi, John W Sweetenham

Prognostic value of regulatory T cells, lymphoma-associated macrophages, and MUM-1 expression in follicular lymphoma treated before and after the introduction of monoclonal antibody therapy: a Southwest Oncology Group Study

单克隆抗体治疗前后滤泡性淋巴瘤中调节性T细胞、淋巴瘤相关巨噬细胞和MUM-1表达的预后价值:西南肿瘤协作组研究

Sweetenham, J W; Goldman, B; LeBlanc, M L; Cook, J R; Tubbs, R R; Press, O W; Maloney, D G; Fisher, R I; Rimsza, L M; Braziel, R M; Hsi, E D